Market Overview

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash

Related MYL
Mylan Adjusts Pricing Terms Of Manufacturing Pacts With Abbot
Bank Of America Raises 2014 Outlook For Mylan Inc
Will Congress Scuttle the AbbVie-Shire Merger? (Fox Business)
Related SLXP
Will Actavis Win Competition For Allergan's Affection?
Progenics Receives $40M Milestone Following FDA Approval of RELISTOR For OIC Patients With Chronic Non-Cancer Pain
Making Money With Charles Payne: 10/17/14 (Fox Business)

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash.

Salix Pharmaceuticals (NASDAQ: SLXP) had $775.90 million in total cash and $869.10 million in total debt for the latest quarter.

Mylan (NASDAQ: MYL) had $412.67 million in total cash for the latest quarter. However, Mylan had $5.37 billion in total debt for the same period.

Hi Tech Pharmacal Co (NASDAQ: HITK) had $104.09 million in total cash and $1.42 million in total debt for the latest quarter.

Akorn (NASDAQ: AKRX) had $38.40 million in total cash and $103.65 million in total debt for the latest quarter.

Posted-In: Drugs-Generic Industry highest cash NASDAQ StocksTrading Ideas

 

Related Articles (AKRX + HITK)

Around the Web, We're Loving...

Get Benzinga's Newsletters